These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

506 related items for PubMed ID: 9265916

  • 1. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB.
    J Clin Psychiatry; 1997; 58 Suppl 10():45-9. PubMed ID: 9265916
    [Abstract] [Full Text] [Related]

  • 2. Subjective experience and D2 receptor occupancy in patients with recent-onset schizophrenia treated with low-dose olanzapine or haloperidol: a randomized, double-blind study.
    de Haan L, van Bruggen M, Lavalaye J, Booij J, Dingemans PM, Linszen D.
    Am J Psychiatry; 2003 Feb; 160(2):303-9. PubMed ID: 12562577
    [Abstract] [Full Text] [Related]

  • 3. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.
    Beasley CM, Tollefson G, Tran P, Satterlee W, Sanger T, Hamilton S.
    Neuropsychopharmacology; 1996 Feb; 14(2):111-23. PubMed ID: 8822534
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [Abstract] [Full Text] [Related]

  • 5. Olanzapine compared with chlorpromazine in treatment-resistant schizophrenia.
    Conley RR, Tamminga CA, Bartko JJ, Richardson C, Peszke M, Lingle J, Hegerty J, Love R, Gounaris C, Zaremba S.
    Am J Psychiatry; 1998 Jul; 155(7):914-20. PubMed ID: 9659857
    [Abstract] [Full Text] [Related]

  • 6. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 7. Extrapyramidal symptom profiles assessed with the Drug-Induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol.
    Inada T, Beasley CM, Tanaka Y, Walker DJ.
    Int Clin Psychopharmacol; 2003 Jan; 18(1):39-48. PubMed ID: 12490774
    [Abstract] [Full Text] [Related]

  • 8. A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
    Breier A, Meehan K, Birkett M, David S, Ferchland I, Sutton V, Taylor CC, Palmer R, Dossenbach M, Kiesler G, Brook S, Wright P.
    Arch Gen Psychiatry; 2002 May; 59(5):441-8. PubMed ID: 11982448
    [Abstract] [Full Text] [Related]

  • 9. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.
    Crawford AM, Beasley CM, Tollefson GD.
    Schizophr Res; 1997 Jul 25; 26(1):41-54. PubMed ID: 9376336
    [Abstract] [Full Text] [Related]

  • 10. Safety of olanzapine.
    Beasley CM, Tollefson GD, Tran PV.
    J Clin Psychiatry; 1997 Jul 25; 58 Suppl 10():13-7. PubMed ID: 9265911
    [Abstract] [Full Text] [Related]

  • 11. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
    Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM, HGDH Study Group.
    Am J Psychiatry; 2003 Aug 25; 160(8):1396-404. PubMed ID: 12900300
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine in treatment-refractory schizophrenia: results of an open-label study. The Spanish Group for the Study of Olanzapine in Treatment-Refractory Schizophrenia.
    Martín J, Gómez JC, García-Bernardo E, Cuesta M, Alvarez E, Gurpegui M.
    J Clin Psychiatry; 1997 Nov 25; 58(11):479-83. PubMed ID: 9413413
    [Abstract] [Full Text] [Related]

  • 13. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P, Lindborg SR, Birkett M, Meehan K, Jones B, Alaka K, Ferchland-Howe I, Pickard A, Taylor CC, Roth J, Battaglia J, Bitter I, Chouinard G, Morris PL, Breier A.
    Can J Psychiatry; 2003 Dec 25; 48(11):716-21. PubMed ID: 14733451
    [Abstract] [Full Text] [Related]

  • 14. Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
    Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.
    J Clin Psychiatry; 2002 Oct 25; 63(10):931-5. PubMed ID: 12416603
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.
    Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.
    Clin Ther; 2003 May 25; 25(5):1420-8. PubMed ID: 12867218
    [Abstract] [Full Text] [Related]

  • 16. Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia.
    Wright P, Birkett M, David SR, Meehan K, Ferchland I, Alaka KJ, Saunders JC, Krueger J, Bradley P, San L, Bernardo M, Reinstein M, Breier A.
    Am J Psychiatry; 2001 Jul 25; 158(7):1149-51. PubMed ID: 11431240
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine versus haloperidol treatment in first-episode psychosis.
    Sanger TM, Lieberman JA, Tohen M, Grundy S, Beasley C, Tollefson GD.
    Am J Psychiatry; 1999 Jan 25; 156(1):79-87. PubMed ID: 9892301
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine versus haloperidol in the treatment of patients with chronic schizophrenia: results of the Japan multicenter, double-blind olanzapine trial.
    Ishigooka J, Inada T, Miura S.
    Psychiatry Clin Neurosci; 2001 Aug 25; 55(4):403-14. PubMed ID: 11442893
    [Abstract] [Full Text] [Related]

  • 19. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER, Sison CE, Alpert M, Connolly B, Crichton J.
    Psychopharmacol Bull; 1998 Aug 25; 34(1):71-4. PubMed ID: 9564201
    [Abstract] [Full Text] [Related]

  • 20. Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.
    Zimbroff DL, Kane JM, Tamminga CA, Daniel DG, Mack RJ, Wozniak PJ, Sebree TB, Wallin BA, Kashkin KB.
    Am J Psychiatry; 1997 Jun 25; 154(6):782-91. PubMed ID: 9167505
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.